Both in Pharmaceuticals
Imunon vs Processa Pharmaceuticals
Over the past year IMNN returned −79.7% and PCSA returned −79.2%; their daily moves had a correlation of 0.09.
IMNN −79.7% PCSA −79.2%Growth of $1, one year, split-adjusted
| Metric | IMNN | PCSA |
|---|---|---|
| Price | $0.9000 | $1.94 |
| Market cap | $5.1M | $5.4M |
| Today | +3.44% | +4.86% |
| 1 month | −27.4% | +30.2% |
| 6 months | −67.5% | −27.1% |
| Year to date | −76.4% | −32.6% |
| 1 year | −80.2% | −80.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$169.7K | $196.3K |
| Dividend yield | — | — |
| Volatility (60d) | 93.8% | 87.6% |
| Short % of float | 1.2% | 2.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).